AVD

$5

$

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.

Next Earnings

2026-02-25

Beta

1.23

Average Volume

Market Cap

Last Dividend

CIK

0000005981

ISIN

US0303711081

CUSIP

030371108

CEO

Douglas A. Kaye

Sector

Basic Materials

Industry

Agricultural Inputs

Full Time Employees

845

IPO Date

1987-03-03

Status

Active

Latest News

Title Headline Publisher Date
American Vanguard (NYSE:AVD) Stock Price Crosses Above 200-Day Moving Average – Time to Sell? Shares of American Vanguard Corporation (NYSE: AVD - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $4.85 and traded as high as $5.35. American Vanguard shares last traded at $5.2440, with a volume of 134,157 shares changing hands. Analysts Set New Price Defense World 2026-02-19 04:17:02
American Vanguard Corporation Announces Executive Appointment and Relocation of Global Headquarters NEWPORT BEACH, CA / ACCESS Newswire / January 14, 2026 / American Vanguard Corporation (NYSE:AVD) has announced, the following change to its executive management team. Mike DiPaola has been appointed Chief Commercial Officer. Accesswire 2026-01-14 16:05:00
Reviewing Mativ (NYSE:MATV) and American Vanguard (NYSE:AVD) Mativ (NYSE: MATV - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Volatility and Risk Mativ has a beta Defense World 2025-12-25 01:47:03
American Vanguard Expects To Have A Good Q4 American Vanguard Corporation maintains a buy rating, supported by improving margins, disciplined OpEx, and attractive valuation amid a challenging agricultural market. AVD expects to generate ~$20 million in free cash flow in FY25, primarily in Q4, with a focus on debt reduction as a key priority. Gross margins are recovering as pricing pressures ease and destocking ends, while adjusted EBITDA has significantly improved due to cost controls. Seeking Alpha 2025-11-28 07:42:20

SEC Filings

Type Filing Date Accepted Date Link
SC 13G/A 2026-02-13 2026-02-13 View Filing
4 2026-01-29 2026-01-29 View Filing
4 2025-12-01 2025-12-01 View Filing
4 2025-12-01 2025-12-01 View Filing
4 2025-12-01 2025-12-01 View Filing
SC 13G 2025-11-12 2025-11-12 View Filing
8-K 2025-11-12 2025-11-12 View Filing
10-Q 2025-11-10 2025-11-10 View Filing
SC 13G 2025-10-30 2025-10-30 View Filing
4 2025-09-05 2025-09-05 View Filing
8-K 2025-08-19 2025-08-19 View Filing
4 2025-08-14 2025-08-14 View Filing
4/A 2025-08-13 2025-08-13 View Filing
SC 13G/A 2025-08-12 2025-08-12 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-11 2025-08-11 View Filing
4 2025-08-08 2025-08-08 View Filing
4 2025-08-08 2025-08-08 View Filing
4 2025-08-08 2025-08-08 View Filing
4 2025-08-08 2025-08-08 View Filing
4 2025-08-08 2025-08-08 View Filing
8-K 2025-08-01 2025-08-01 View Filing
10-Q 2025-07-31 2025-07-31 View Filing
SC 13G/A 2025-07-29 2025-07-29 View Filing
SC 13G/A 2025-07-16 2025-07-16 View Filing
SC 13G/A 2025-07-15 2025-07-15 View Filing
8-K 2025-07-07 2025-07-07 View Filing
4 2025-06-12 2025-06-12 View Filing
8-K 2025-06-09 2025-06-09 View Filing
8-K 2025-06-06 2025-06-06 View Filing
10-Q 2025-06-06 2025-06-06 View Filing
10-K/A 2025-06-02 2025-05-30 View Filing
DEF 14A 2025-05-29 2025-05-29 View Filing
10-K 2025-05-29 2025-05-29 View Filing
NT 10-Q 2025-05-12 2025-05-12 View Filing
8-K 2025-05-08 2025-05-08 View Filing
8-K 2025-04-21 2025-04-21 View Filing
8-K 2025-04-04 2025-04-04 View Filing
3 2025-03-19 2025-03-19 View Filing
3 2025-03-18 2025-03-18 View Filing
3 2025-03-18 2025-03-18 View Filing
8-K 2025-03-14 2025-03-14 View Filing
NT 10-K 2025-03-14 2025-03-14 View Filing
8-K 2025-03-14 2025-03-14 View Filing
4 2025-01-24 2025-01-24 View Filing
4 2025-01-21 2025-01-21 View Filing
3 2025-01-14 2025-01-14 View Filing
3 2025-01-10 2025-01-10 View Filing
4 2024-12-17 2024-12-17 View Filing
8-K 2024-12-13 2024-12-13 View Filing
8-K 2024-12-06 2024-12-05 View Filing
4 2024-11-18 2024-11-18 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
10-Q 2024-11-12 2024-11-12 View Filing
8-K 2024-11-12 2024-11-12 View Filing
SC 13G/A 2024-10-31 2024-10-31 View Filing
4 2024-10-21 2024-10-21 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-05 2024-09-05 View Filing
4 2024-09-03 2024-09-03 View Filing
4 2024-09-03 2024-09-03 View Filing
4 2024-09-03 2024-09-03 View Filing
4 2024-08-30 2024-08-30 View Filing
4 2024-08-30 2024-08-30 View Filing
8-K 2024-08-23 2024-08-23 View Filing
8-K 2024-08-09 2024-08-09 View Filing
10-Q 2024-08-09 2024-08-09 View Filing
3 2024-08-06 2024-08-06 View Filing
8-K 2024-07-17 2024-07-17 View Filing
SC 13G 2024-07-11 2024-07-11 View Filing
8-K 2024-07-09 2024-07-09 View Filing
8-K 2024-06-11 2024-06-11 View Filing
4 2024-06-07 2024-06-07 View Filing
4 2024-06-07 2024-06-07 View Filing
4 2024-06-06 2024-06-06 View Filing
4 2024-06-06 2024-06-06 View Filing
4 2024-06-06 2024-06-06 View Filing
4 2024-06-06 2024-06-06 View Filing
4 2024-06-06 2024-06-06 View Filing
4 2024-06-06 2024-06-06 View Filing
4 2024-05-17 2024-05-17 View Filing
4 2024-05-17 2024-05-17 View Filing
4 2024-05-17 2024-05-17 View Filing
8-K 2024-05-10 2024-05-10 View Filing
10-Q 2024-05-09 2024-05-09 View Filing
DEF 14A 2024-04-25 2024-04-25 View Filing
4 2024-04-11 2024-04-11 View Filing
3 2024-04-09 2024-04-09 View Filing
10-K 2024-03-28 2024-03-27 View Filing
8-K 2024-03-18 2024-03-18 View Filing
3 2024-03-15 2024-03-15 View Filing
NT 10-K 2024-03-15 2024-03-15 View Filing
8-K 2024-03-12 2024-03-12 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Keltner Channel Strategy 25.87% 1 368 0.01 0.06 33.49
ADX 16.60% 1 530 0.01 0.04 24.22
Choppiness Index Strategy 15.51% 1 903 0.01 0.03 23.14
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xxx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xxx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xxx x xxxx xxxxx
xxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxx xxxxxxx% x xxx x xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx x xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xxx x xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xxx x x xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxx xxxxxxxx% xxxx xxx x x xxxx
xxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx x x xxxx
xxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx x
xxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx x
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx